Bridge Advisory’s AbbVie ABBV Stock Holding History

Bridge Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,299	Closed	-$207K	–	132
2023 Q1	$207K	Buy	+1,299	New	+$199K	0.08%	118
2022 Q2	–	Sell	-1,369	Closed	-$222K	–	118
2022 Q1	$222K	Buy	+1,369	New	+$199K	0.1%	89

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bridge Advisory's ABBV Position: Q2 2023 in Review

Bridge Advisory sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 1,299 shares — an estimated $207K sold.

Bridge Advisory first reported a position in ABBV in Q1 2022 and held it in 2 quarters. The position peaked at $222K in Q1 2022. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

Bridge Advisory reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
Bridge Advisory sold 1,299 AbbVie shares in Q2 2023, an estimated $207K.
Bridge Advisory first reported a position in AbbVie in Q1 2022 and held it in 2 quarters.
Bridge Advisory's AbbVie position peaked at $222K in Q1 2022.
3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Bridge Advisory's 13F filing for Q2 2023, filed 17 Jul 2023.